CLINICAL_TRIALS
trial_result
· 2022-09-16
Clinical Trial Update: A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea [Phase 2]
Summary
A Phase 2 clinical trial evaluated safety and efficacy of B244 in adults with mild to moderate rosacea; study completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AOBiome LLC | Conditions: Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2022-09-16